GI Cancer
GI Cancer
Advertisement
Amanda Brink, DNP, APRN, FNP-BC, AOCNPGI Cancer | February 15, 2024
February is Gallbladder and Bile Duct Cancer Awareness Month, a time to draw attention to this often-overlooked cancer.
Read More
Cecilia BrownGI Cancer | February 14, 2024
An online quiz provided over 30,000 CRC screening recommendations from July 2022-August 2023.
Cecilia BrownGI Cancer | February 14, 2024
Researchers uncovered a "particularly pronounced" link between early-onset rectal cancer and a certain "red flag" sign.
Cecilia BrownGI Cancer | February 13, 2024
Results of a recent study show why “nursing care of patients with CRC stoma should not be ignored."
Cecilia BrownGI Cancer | February 12, 2024
Learn how lavender oil can help with odor management, ostomy adjustment, and quality-of-life outcomes in these patients.
Martha Raymond, MAGI Cancer | February 2, 2024
Martha Raymond, MS, of the GI Cancers Alliance, speaks about the important role that oncology nurses play in GI cancer care.
Cecilia BrownNews | February 7, 2024
Psychosocial care and support are critical parts of cancer care, according to the International Psycho-Oncology Society.
Timothy J. Brown, MDGI Cancer | January 24, 2024
Timothy Brown, MD, discusses research on the treatment strategy at the 2024 ASCO GI Cancers Symposium.
Teresa Hagan Thomas, PhD, RNBest Practices | January 24, 2024
Certain patients are less likely to use hospice services, but oncology nurses can help ensure the option is made available.
Yelena Janjigian, MDGI Cancer | January 24, 2024
MATTERHORN is the “first study to attempt to standardize therapy perioperatively with FLOT,” Dr. Janjigian said.
Martha Raymond, MAGI Cancer | January 19, 2024
Martha Raymond, MA, discusses eye-opening findings from a study presented at the 2024 ASCO GI Cancers Symposium.
Jessica A. Zerillo, MD, MPHGI Cancer | January 19, 2024
Jessica A. Zerillo, MD, MPH, discusses research on the tool that she presented at the 2024 ASCO GI Cancer Symposium.
Cecilia BrownGI Cancer | January 18, 2024
Researchers wanted to understand how patients perceive the utility of ctDNA testing and how it affects fear of recurrence.
Cecilia BrownGI Cancer | January 18, 2024
A combined analysis of SPOTLIGHT and GLOW showed nausea occurred in 58% of patients with the first infusion of zolbetuximab.
Cecilia BrownGI Cancer | January 18, 2024
The study suggests that leaving the primary undetectable tumor in situ until local regrowth may result in worse outcomes.
Cecilia BrownGI Cancer | January 18, 2024
New research shows why the importance of addressing malnutrition in patients with GI cancer "cannot be overstated."
Cecilia BrownGI Cancer | December 19, 2023
Nearly all patients received trifluridine/tipiracil plus bevacizumab as a second-line treatment.
Cecilia BrownGI Cancer | November 29, 2023
Researchers evaluated how the program affected quality of life, emotional distress, fatigue, physical activity, and more.
Cecilia BrownGI Cancer | December 19, 2023
Many adults rate themselves as having "inadequate" health insurance literacy.
Cecilia BrownGI Cancer | November 28, 2023
With rising rates of young-onset CRC, it is critical to ensure this population of patients receives genetic evaluations.
Advertisement
Advertisement
Advertisement